Optimal use of BTK inhibitors in Waldenström’s macroglobulinemia: combination or single drug approach? by Eirini Solia, Efstathios Kastritis

Get full text

Disease control should be the goal of therapy for WM patients by Efstathios Kastritis, Meletios A. Dimopoulos

Get full text

Monoclonal antibody-based therapies for Waldenström's macroglobulinemia by Despina Fotiou, Foteini Theodorakakou, Efstathios Kastritis

Get full text

Daratumumab plus CyBorD for patients with newly diagnosed light chain (AL) amyloidosis by Foteini Theodorakakou, Meletios A. Dimopoulos, Efstathios Kastritis

Get full text

Systemic AL Amyloidosis: Current Approaches to Diagnosis and Management by Despina Fotiou, Meletios Athanasios Dimopoulos, Efstathios Kastritis

Get full text

Future Developments in the Treatment of AL Amyloidosis by Foteini Theodorakakou, Despina Fotiou, Meletios A. Dimopoulos, Efstathios Kastritis

Get full text

De Novo AL Amyloidosis in Renal Allograft and Anti-CD38 Monoclonal Antibody Treatment by Despina Fotiou, Chrysanthi Skalioti, George Liapis, Smaragdi Marinaki, Efstathios Kastritis

Get full text

<i>MYD88</i> Wild Type in IgM Monoclonal Gammopathies: From Molecular Mechanisms to Clinical Challenges by Tina Bagratuni, Alexandra Papadimou, Kostantina Taouxi, Meletios A. Dimopoulos, Efstathios Kastritis

Get full text

Exercise-Induced Changes in Tumor Growth via Tumor Immunity by Polyxeni Spiliopoulou, Maria Gavriatopoulou, Efstathios Kastritis, Meletios Athanasios Dimopoulos, Gerasimos Terzis

Get full text

Editorial: Exploiting the Immune System to Treat Multiple Myeloma: From Transplantation to Novel Treatment Approaches by Niels W. C. J. van de Donk, Efstathios Kastritis, Francesca Gay

Get full text

Treatment of light chain deposition disease with bortezomib and dexamethasone by Efstathios Kastritis, Magdalini Migkou, Maria Gavriatopoulou, Panos Zirogiannis, Valsamakis Hadjikonstantinou, Meletios A. Dimopoulos

Get full text

The International Prognostic Scoring System for Waldenström’s macroglobulinemia is applicable in patients treated with rituximab-based regimens by Meletios Athanasios Dimopoulos, Efstathios Kastritis, Sossana Delimpassi, Athanasios Zomas, Marie Christine Kyrtsonis, Konstantinos Zervas

Get full text

The patient pathway in ATTR-CM in Greece and how to improve it: A multidisciplinary perspective by Efstratios A. Apostolou, Anna-Maria Fontrier, Georgios K. Efthimiadis, Efstathios Kastritis, John Parissis, Panos Kanavos

Get full text

Conservative Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw in Multiple Myeloma Patients by Pelagia I. Melea, Ioannis Melakopoulos, Efstathios Kastritis, Christina Tesseromatis, Vasileios Margaritis, Meletios A. Dimopoulos, Evangelos Terpos

Get full text

Integrated Network-Based Analysis of Diseases Associated with Amyloid Deposition Through a Disease–Protein–Drug Network by Aikaterini E. I. Rizou, Georgia I. Nasi, Avgi E. Apostolakou, Meletios A. Dimopoulos, Efstathios Kastritis, Vassiliki A. Iconomidou

Get full text

Serum Dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis. Reduction post-zoledronic acid administration by Ersi Voskaridou, Dimitrios Christoulas, Charoula Xirakia, Konstantinos Varvagiannis, Georgios Boutsikas, Antonios Bilalis, Efstathios Kastritis, Athanasios Papatheodorou, Evangelos Terpos

Get full text

PB2150: CARDIAC AMYLOID REACHING FOR EXTENDED SURVIVAL (CARES) TRIALS: 2 PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED, PHASE 3 TRIALS ASSESSING CAEL-101 IN PATIENTS WITH MAYO STAGE... by Ashutosh Wechalekar, Giovanni Palladini, Maria Angelica Molina, Efstathios Kastritis, Juliana Ianus, Julia Catini, C Cristina Quarta, Michaela Liedtke

Get full text

CMR in AL Amyloidosis and Sarcoidosis. Do Look for Splenic Involvement by Niki Lama, MD, Alexandros Briasoulis, MD, Elias Gialafos, Efstratios Karavasilis, PhD, Foteini Theodorakakou, Efstathios Kastritis, MD, Nikolaos Kelekis, MD

Get full text

Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone-containing regimens and the impact of novel agents by Efstathios Kastritis, Athanasios Anagnostopoulos, Maria Roussou, Dimitra Gika, Charis Matsouka, Despina Barmparousi, Irini Grapsa, Erasmia Psimenou, Aristotle Bamias, Meletios Athanasios Dimopoulos

Get full text

Assessing the prognostic utility of hematologic response for overall survival in patients with newly diagnosed AL amyloidosis: results of a meta-analysis by Efstathios Kastritis, Arpit Misra, Laura Gurskyte, Florint Kroi, Andre Verhoek, Jessica Vermeulen, Eric Ammann, Annette Lam, Sarah Cote, Ashutosh D. Wechalekar

Get full text